Approvals/TGA/SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler

Approved

STANDARD

SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler

Orion Pharma (AUS) Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: e4f577386f88e8ae
Product Name: SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler
Artg Id: 338157
Artg Name: SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler
Sponsor: Orion Pharma (AUS) Pty Limited
Company Detail Path: /organization/orion-pharma-aus-pty-limited
Artg Date: 2022-10-28
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/75b41edd49881f2fc16530f9a0084f9b.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/f03e90a0b67f070a05cff5f27c56c89f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

e4f577386f88e8ae

Type

Standard